Skip to content
General News, Medical Health Aged Care

CDU EXPERT: Commonwealth supported places for rural-trained medical students will get more doctors to stay where they are needed most, expert says

Charles Darwin University 2 mins read

7 JULY 2023

The Federal Government has announced that universities can now apply for additional Commonwealth supported places for rural-trained medical students, as well as funding for new regional training facilities. CDU Foundation Dean of the CDU Menzies School of Medicine, Professor Dianne Stephens OAM said this is critically needed to help solve the Northern Territory’s medical workforce crisis.

Charles Darwin University (CDU) Foundation Dean CDU Menzies School of Medicine, Professor Dianne Stephens OAM

To arrange an interview please email [email protected], or contact Emily Bostock on 0432 417 518.

The following quotes can be attributed to Professor Dianne Stephens:

“The Northern Territory is experiencing a medical workforce crisis and is currently the only jurisdiction in Australia that does not have Commonwealth supported medical places.”

“CDU welcomes the release of this grant for 80 new medical places and will be making an application for 40 of those places to establish the CDU Menzies School of Medicine at the only university headquartered in the NT.”

“The establishment of the CDU Menzies school of Medicine is a critical step to developing a sustainable medical workforce pipeline for the Northern Territory and to improve health outcomes for Territorians.”

“Evidence shows that medical students drawn from the local community and trained locally are more likely to stay local to deliver health services in their region.”

“The CDU Menzies School of Medicine is critical to the development of a sustainable local workforce; it will be a value add to the NT community and will help provide an incentive for students to come and study in the NT.”

“The CDU Menzies School of Medicine will also help to attract senior clinicians into the NT by providing academic and research pathways which will highly benefit the NT community.”

“CDU Menzies School of Medicine will provide increased opportunity for training First Nations doctors in the NT and more First Nations doctors are needed to help improve health outcomes for the NT’s most vulnerable population.”


Contact details:

Emily Bostock, research communications officer

[email protected]

0432 417 518

More from this category

  • Medical Health Aged Care
  • 10/03/2026
  • 20:11
Ferring Pharmaceuticals

For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025

Ferring’s total revenues for 2025 exceeded €2.5 billion, an increase of 10% from 2024, mainly driven by our flagship product Menopur® Continued ramp-up in…

  • Contains:
  • Legal, Medical Health Aged Care
  • 10/03/2026
  • 17:30
Maddens Lawyers

Thousands register to participate in the Dr Lanzer Class Action

Patients who underwent cosmetic surgery at the Lanzer Clinics have until 4.00pm Friday 10 April to register or opt out of a class action set for trial in the Supreme Court of Victoria in September. The class action alleges that Dr Daniel Lanzer and his colleagues Dr Daniel Aronov, Dr Ryan Wells, Dr Alieza Fallahi, Dr George Wong, and Dr Daniel Darbyshire engaged in misleading and negligent practices while performing cosmetic surgeries, with many former patients left with injuries and ongoing pain. Psychologist Candice Wainstein, who is the wife of Dr Aronov, is also a defendant. Maddens Lawyers principal Kathryn…

  • Contains:
  • Medical Health Aged Care
  • 10/03/2026
  • 16:28
Phebra

Phebra launches Rapiblyk® in Australian healthcare settings

Australian Pharmaceutical company Phebra (‘Company’) has announced the launch of Rapiblyk® (landiolol hydrochloride), an ultra‑short‑acting, cardio-selective receptor antagonist, indicated for rapid control of ventricular rate in patients with severe, acute cardiac arrhythmias (irregular rapid heart rate) in critical care settings. Clinical studies have demonstrated that Rapiblyk® enables safe, effective heart rate control with limited impact on blood pressure and inotropy (heart contractility). Rapiblyk® has a very short half life delivering a fast onset and offset of action. This provides clinicians with a higher level of precision in life-threatening situations. Phebra CEO Andre Vlok highlighted how Rapiblyk® strengthens the company's critical…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.